New and emerging concepts in the use of denosumab for the treatment of osteoporosis

about

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

Item

http://www.wikidata.org/entity/Q58583955

description

scientific article published on 22 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@en

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@nl

type

Item

label

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@en

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@nl

prefLabel

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@en

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@nl

P1476

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

@en

P2093

E Michael Lewiecki

http://www.w3.org/2001/XMLSchema#string

P2860

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Denosumab in postmenopausal women with low bone mineral density

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.

Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.

P304

209-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X18805759

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Michael Lewiecki

P577

2018-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386439

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

6204627

http://www.w3.org/2001/XMLSchema#string